One World Cannabis discovers, develops, and commercializes cannabis-based therapeutic products and treatments. One World Cannabis intends to investigate specific cannabis strains, combinations of the cannabinoids THC and CBD, and optimal dosages.
The companys first clinical trials will explore potential treatments for fibromyalgia, psoriasis, basal cell carcinoma, post-traumatic stress disorder, and seizures. The second set of clinical trials will focus on the development of cannabis medicines for Crohns disease, Parkinsons disease, Tourettes syndrome, migraines, chronic pain, Alzheimers disease, pediatric epilepsy, prostate cancer, and diabetes.
One World Cannabis is a wholly owned Israeli subsidiary of OWC Pharmaceutical Research Corp.
Cumulative Funding Raised Over Time ($)
Employees Over Time
One World Cannabis Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 14, 2020
www.prnewswire.com
OWC Pharmaceutical Research Corp. Announces A New Distribution Agreement With Can It Industries, Florida US
#Partners
Aug 19, 2020
www.prnewswire.com
OWC Pharmaceutical Research Corp. Letter to Shareholders for Upcoming Proxy Voting